Daniel Snyder

Daniel Snyder is an Associate Director in the Pharmacovigilance Oversight and Analytics unit of the Lifecycle Safety organization at IQVIA. In this role, they manage, author, and finalize aggregate reports; conduct ongoing literature safety surveillance; and serve as the principal owner of deliverables while collaborating with various functional groups. Daniel has over ten years of experience in clinical research and pharmacovigilance, having held positions at organizations including Ashfield, Duke University Health System, and Rho. They earned a Bachelor of Science degree in Biology from Longwood University.